SMTL ID : 5boc.1

Crystal structure of topoisomerase ParE inhibitor

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.20 Å

Oligo State

monomer

Ligands

1 x TSJ: 3-methyl-4-({3-[3-methyl-5-(trifluoromethyl)phenyl]-1H-pyrazol-5-yl}carbamoyl)benzoic acid(Non-covalent)

TSJ.1: 12 residues within 4Å: Chain A: I.48, N.51, E.55, V.76, D.78, R.81, G.82, M.83, F.99, S.124, T.172, V.174 12 PLIP interactions: 12 interactions with chain A Hydrophobic interactions: A:I.48, A:N.51, A:V.76, A:R.81, A:T.172, A:V.174 Hydrogen bonds: A:E.55, A:E.55, A:E.55 Water bridges: A:G.82 Salt bridges: A:R.81 pi-Cation interactions: A:R.81

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Chen, G.Y. et al., Application of Fragment-based Drug Discovery against DNA GyraseB. To be published

Release Date

2015-06-17

Peptides

DNA topoisomerase 4 subunit B: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

DNA topoisomerase 4 subunit B

Related Entries With Identical Sequence